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INTRODUCTION
Chronic granulomatous disease (CGD) is a rare hereditary
disorder characterized by recurrent life-threatening bacterial
and fungal infections (1). The underlying defect in CGD is
an inability of phagocytes to produce reactive oxygen species
(ROS) as a result of defects in NADPH oxidase (2). NADPH
oxidase is composed of several structural and regulatory pro-
teins. Two of these, gp91-phox and p22-phox, are integral
membrane proteins that form flavocytochromeb558, the elec-
tron-transport center of the oxidase. The cytosolic proteins,
p40-phox, p47-phox, and p67-phox, exist as a tight complex
in the cytosol of resting phagocytes (3, 4). After ingestion of
microbes into phagosomes, the cytosolic proteins translocate
to the membrane to complex with the flavocytochrome to
form activated NADPH oxidase, which generates ROS (5). 
CGD is a genetically heterogeneous disease caused by defects
in the genes encoding any of the NADPH oxidase compo-
nents. Approximately 60% of CGD patients showed an X-
linked inheritance, which is caused by mutations in the CYBB
gene encoding gp91-phox. Autosomal recessive forms of CGD
are caused by mutations in one of three genes: the CYBA
(p22-phox) gene, the NCF1 (p47-phox) gene, and the NCF2
(p67-phox) gene. Mutations in these three genes collectively
account for about 30-40% of CGD patients (6). Mutations
in the p67-phox and p22-phox genes are less common, and
to date no patients have been reported with defects in p40-
phox (6). 
Although the prevalence of CGD may actually be higher
than reported because of the under-diagnosis of milder phe-
notypes, the estimated prevalence of CGD is between 1 in
200,000 and 1 in 250,000 individuals, with variable occur-
rence in different countries (6-11). According to a collation
by the Korean College of Pediatric Clinical Immunology, the
prevalence of CGD from 2001 to 2005 in Korea was 0.9 in
1,000,000 individuals. Most regions of Korea had similar
prevalence of CGD (from 0.4 to 1.7). The prevalence of CGD
on Jeju Island was a surprising 20.7, showing 10-50 times
higher than that in other regions of Korea (paper in prepa-
ration). The aim of this study was to examine the genotype
of CGD patients on Jeju Island. 
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Genetic Analysis of 10 Unrelated Korean Families with p22-phox-
deficient Chronic Granulomatous Disease: An Unusually Identical
Mutation of the CYBA Gene on Jeju Island, Korea
Chronic granulomatous disease (CGD) is a rare hereditary disorder characterized
by recurrent life-threatening bacterial and fungal infections. The underlying defect
in CGD is an inability of phagocytes to produce reactive oxygen species as a result
of defects in NADPH oxidase. Considering that CGD generally affects about 3-4 in
1,000,000 individuals, it is surprising that the prevalence of CGD on Jeju Island is
20.7 in 1,000,000 individuals. We performed genetic analysis on 12 patients from
10 unrelated families and found that all patients had an identical homozygous sin-
gle-base substitution of C to T in exon 1 (c.7C>T) of the CYBA gene, which was
expected to result in a nonsense mutation (p.Q3X). Because Jeju Island has long
been a geologically isolated region, the high prevalence of CGD on Jeju Island is
presumably associated with an identical mutation inherited from a common ances-
tor or proband.
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MATERIALS AND METHODS
Patients
Between January 1993 and December 2007, the available
data for CGD patients on Jeju Island were obtained from the
medical records of Jeju National University Hospital. The
diagnosis of CGD was based on a history of recurrent infec-
tions and previously affected family members. The diagno-
sis was confirmed by an impaired phorbol myristate acetate
(PMA)-stimulated nitroblue tetrazolium (NBT) test and/or
dihydrorhodamine-1,2,3 (DHR) flow cytometry assay. Twelve
patients with CGD (3 males and 9 females) from 10 unre-
lated families were enrolled for Western blot and mutation
analysis. All available family members were analyzed for con-
firming the heterozygous status. 
This study was approved by the Institutional Review Board
of Jeju National University Hospital (2006-14), and informed
consent for genetic analysis was obtained from all patients
and/or their parents.
DHR flow cytometry 
DHR flow cytometry was used to evaluate the generation
of ROS by phagocytic cells as previously described (12). Red
blood cells were lysed by mixing 400 μ L of whole blood with
4 mL of lysis buffer (174 mM ammonium chloride, 20 mM
sodium bicarbonate, and 1 mM EDTA). White blood cells
(WBCs) suspended in Hank’s buffered salt solution contain-
ing 0.1% bovine serum albumin were loaded with 1 mM
EDTA, followed by 1 unit/μ L catalase (Roche Diagnostic
Cooperation, Indianapolis, IN, U.S.A.) and 100 mM DHR
(Molecular Probes, Eugene, OR, U.S.A.). PMA (Sigma-Al-
drich, St. Louis, MO, U.S.A.) was added to the cells at a final
concentration of 20 ng/mL, and the cells were incubated for
15 min. After incubation, the cells that had formed rhodamine
by oxidizing DHR were counted with an EPICS
� XL flow
cytometer (Coulter, Miami, FL, U.S.A.).
Western blot analysis of the NADPH oxidase components
WBCs were solubilized in a lysis buffer containing 100 mM
KCl, 10 mM NaCl, 10 mM HEPES, 1 mM EDTA (pH 7.4),
0.1 mM DTT, 1 mM PMSF, 10 μ g/mL chymostatin, 1 μ g/
mL protease inhibitor cocktail (Sigma-Aldrich), 1% Triton
X-100, 1% deoxycholic acid, 1% NP-40, and 0.05% SDS.
The protein content of the cell lysate was resolved by 5-20%
SDS-PAGE and electroblotted onto nitrocellulose membranes.
Following a blocking step, the membranes were incubated
for 2 hr with the following primary antibodies diluted 1:1,000:
polyclonal anti-p22-phox (FL-195), anti-p47-phox (H-195),
anti-p67-phox (H-300), and anti-p40-phox (D-8) (Santa Cruz
Biotechnology, Santa Cruz, CA, U.S.A.); and anti-gp91-phox
(Upstate, Lake Placid, NY, U.S.A.). After multiple washing
steps, the membranes were incubated with HRP-conjugat-
ed anti-rabbit or anti-mouse IgG (1:10,000 dilution; Vector,
Burlingame, CA, U.S.A.). Immunoblot signals were visual-
ized with an Enhanced Chemiluminescence Detection Sys-
tem (Pierce Biotechnology, Rockford, IL, U.S.A.). 
Isolation of total RNA and RT-RCR
Total RNA was extracted from WBCs using an RNeasy
�
mini kit (QIAGEN, Valencia, CA, U.S.A.), following the
manufacturer’s instructions. First-strand cDNA was synthe-
sized from 2 μ g of RNA with 25 ng/mL Oligo dT (Promega,
Madison, WI, U.S.A.), 0.5 mM dNTP mix, 0.2 unit/μ L Om-
niscript (QIAGEN), and 0.5 unit/μ L RNase inhibitor. The
reaction was incubated at 37℃ for 60 min. The synthesized
cDNA was amplified using primers (Forward, 5′ -ATG GGG
CAG ATC GAG TGG GC-3′ and Reverse, 5′ -TCA CAC
GAC CTC GTC GGT CA-3′ ; CYBA accession number, NM_
000101) in a 50-μ L PCR reaction containing 0.2 mM dNTP
mix, 0.4 μ M primer, and 1.25 units of Taq polymerase (Pro-
mega). The PCR conditions were 35 cycles of denaturation
at 94℃ for 15 sec, annealing at 62℃ for 30 sec, and exten-
sion at 72℃ for 1 min. The RT-PCR products were sepa-
rated in a 2% agarose gel and stained with ethidium bromide
for visualization. 
Isolation and amplification of genomic DNA of CYBA 
Genomic DNA was extracted from peripheral blood using
a Wizard
� genomic DNA purification kit (Promega) accord-
ing to the manufacture’s protocol. The six exons of CYBA
and the exon-intron junctions were amplified by PCR as pre-
viously described (13). Primers used for 5′ and 3′ untranslated
region are as follow; 5′ untranslated region: forward 5′ -AAA
CCA CCA AGT GCC TCG GAT G-3′ and reverse 5′ -TGA
GCC AAT GTG GGG TTT GAG G-3′ , 3′ untranslated
region: forward 5′ -CAG GCC GAC CCA GGT CCT GGC
-3′ and reverse 5′ -CGG CCC CAG GCA GAG GCT CA-3′ .
PCR was performed in a 50-μ L reaction mixture containing
10 pM of each primer, 0.2 mM dNTPs, 100 mM Tris-HCl,
pH 8.3, 1.5 mM MgCl2, and 2.0 units of Taq polymerase
(Promega). The amplification conditions were 35 cycles of
95℃ for 1 min, 59℃ for 1 min, and 72℃ for 1 min; fol-
lowed by a final extension time of 5 min at 72℃. The PCR
products were separated in a 1.5% agarose gel and stained
with ethidium bromide for visualization.
Sequence analysis
PCR-amplified products were purified using a QIAquick
PCR purification kit (QIAGEN, Hilden, Germany) and ana-
lyzed by direct sequencing in both directions using an ABI-
Prism BigDye Terminator Cycle Sequencing Ready Reaction
kit and an ABI Prism 3130 XL Genetic Analyzer (AppliedIdentical Mutation of the CYBA Gene in Korean Families 1047
Biosystems, Foster City, CA, U.S.A.). Primers for the sequenc-
ing reactions were the same as those used for PCR. The sequ-
ences obtained from CGD patients and healthy controls were
compared with GenBank data (GenBank accession number,
NM_000101) and submitted for BLAST analysis.
RESULTS
Between 1993 and 2007, 17 patients from 11 unrelated
families on Jeju Island were identified as having CGD. There
were 7 males and 10 females, and 5 families (45%) had mul-
tiple affected siblings. The diagnosis of CGD was made at a
mean age of 2.1 yr (median, 0.5 yr; range 0.1-5.4 yr). Four
patients (24%) died during the period, at a mean age of 4.7
yr (range, 0.9 to 14.3 yr). Judging from this study, the preva-
lence of CGD on Jeju Island is 23.1 in 1,000,000 individu-
als (Statistics from Jeju Special Self-Governing Province,
2007). 
Among the CGD patients, 12 patients from 10 families
were analyzed by DHR flow cytometric assay and Western
blot analysis (Table 1). The ages of the patients at the time
of genetic analysis ranged from 3.3 to 28.2 yr. With the DHR
flow cytometric assay, all of the patients showed an absence
of ROS production, but all other family members with nor-
mal phenotype did not show any impairment compared with
healthy controls (Fig. 1). Western blot analysis demonstrat-
ed the absence of p22-phox expression in all patients, while
the expression of gp91-phox, p47-phox, p67phox, and p40-
phox was normal in all patients (Fig. 2). Thus, all the patients
exhibited the A22°biochemical phenotype of the disease.
The mRNA of CYBA gene was reverse transcribed as des-
cribed above. The cDNA for p22-phox in all patients and
family members did not differ in size from that in healthy
Family Patient
Age
(yr)
Age at
diagnosis
Gender
NBT/DHR
test (%)
Phox protein expression
gp91 p22 p47 p67 p40
I1 2 8
+2 5
+3 F 0 Normal Null Normal Normal Normal
II 2 14
+3*5
+5 M0
� ND ND ND ND ND
3 20
+8 3
+11 F 0 Normal Null Normal Normal Normal
III 4 19
+9 1
+3 F 0 Normal Null Normal Normal Normal
51 4
+5 2
+3 F 0 Normal Null Normal Normal Normal
IV 6 1
+1* ND F ND ND ND ND ND ND
70
+11*0
+9 M0
� ND ND ND ND ND
81 2
+9 0
+10 F 0 Normal Null Normal Normal Normal
V9  1 2
+6 0
+2 F 0 Normal Null Normal Normal Normal
10 2
+7*0
+5 M0
� ND ND ND ND ND
VI 11 10
+6 0
+6 M 0 Normal Null Normal Normal Normal
VII 12 9
+10 0
+5 F 0 Normal Null Normal Normal Normal
13 4
+1 0
+1 M 0 Normal Null Normal Normal Normal
VIII 14 9
+4 4
+1 M 0 Normal Null Normal Normal Normal
IX 15 8
+5 4
+6 F 0 Normal Null Normal Normal Normal
X1 6 3
+4 2
+10 F 0 Normal Null Normal Normal Normal
Table 1. Characteristics of CGD patients in Jeju, Korea 
*age at death; 
� confirmed by NBT test.
CGD, Chronic granulomatous disease; NBT, Nitroblue tetrazolium; DHR, Dihydrorhodamine-1,2,3; Phox, Phagocyte oxidase; ND, Not determined.
Fig. 1. Dihydrorhodamine-1,2,3 (DHR) flow cytometric analysis of granulocyte oxidative activity in family III. There was no difference in pha-
gocyte oxidative activity between the parents of patient 4 and healthy controls after no stimulation (black) or stimulation with PMA (red). A
lack of phagocyte oxidative activity after stimulation with PMA was observed in patient 4.
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controls (Fig. 3). Sequence analysis of genomic DNA for
CYBA gene revealed that all patients had an identical, homo-
zygous, single-base substitution of C to T in exon 1 (c.7C>T),
which was expected to result in a nonsense mutation (p.Q3X).
The genomic DNA sequencing results for both parents of
all the patients showed a double signal at the same position,
which indicated they were heterozygous for the mutation in
the CYBA gene (Fig. 4). This mutation has been previously
reported at the same position in Japanese patients (14, 15). 
Fig. 2. Western blot analysis of NADPH oxidase components in fam-
ily III. Western blot analysis demonstrated the absence of p22-phox
expression in patients 4 and 5, but the expression of gp91phox,
p47-phox, p67phox, and p40-phox were normal. There was no
abnormal expression of any NADPH oxidase components in other
family members.
F, Father of patients 4 and 5; M, Mother of patients 4 and 5; P4,
Patient 4; S, Elder sister of patient 5; P5, Patient 5; B, Younger broth-
er of patient 5.
FM P 4 S P 5 B
gp91-phox
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100
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Fig. 3. RT-PCR of CYBA cDNA from family III. The mRNA of p22-phox
was reverse transcribed as described above. There was no difference
in size between the p22-phox cDNAs in family III and those in healthy
controls. 
F, Father of patients 4 and 5; M, Mother of patients 4 and 5; P4, Pati-
ent 4; S, Elder sister of patient 5; P5, Patient 5; B, Younger brother of
patient 5.
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MG QI
AT G / GG G / TAG / AT
M G STOP
Fig. 4. Sequence analysis of the CYBA gene from family III. (A) Pedi-
gree of family III. (B) Sequence analysis of the CYBA gene from
family III. Patients 4 and 5 had an identical, homozygous, single-
base substitution of C- to T in exon 1 (c.7C>T), which was expect-
ed to result in a nonsense mutation (p.Q3X). The sequencing results
for other family members showed a double signal at the same posi-
tion, indicating that they were heterozygous for the mutation. 
*site of mutation. 
F, Father of patients 4 and 5; M, Mother of patients 4 and 5; P4,
Patient 4; S, Elder sister of patient 5; P5, Patient 5; B, Younger broth-
er of patient 5.
CGD, Chronic granulomatous disease; UT region, Untranslated region;
NA, Not applicable; NR, Not registered.
Nucleotide changes Amino acid changes References
-930 A>G (5′ UT region) NA  16
36 G>A 13 Q > Q (silent) NR
214 C>T 72 H > Y 16
521 C>T 174 A > V 16
612 A>G (+24 of 3′ UT region) NA 16, 21
646 C>T (+49 of 3′ UT region) NA  NR
Table 2. Single nucleotide substitution within the CYBA gene in
CGD patientsIdentical Mutation of the CYBA Gene in Korean Families 1049
In addition to the mutation described above, six different
single nucleotide substitutions (SNP) within the CYBA gene
were detected in all patients in the same manner during the
course of genetic analysis (Table 2).
DISCUSSION
Jeju is a large island off southwest of Korean peninsula.
The total population of Jeju Island is 563,388 (Statistics of
Jeju Special Self-Governing Province, 2007). Mt. Halla rises
in the center of Jeju Island, dividing it into two geographi-
cally separated regions, Jeju City and Seogwipo City. In this
study, 17 patients from 11 unrelated families on Jeju Island
were identified as having CGD; 14 patients were from Seog-
wipo City and three from Jeju City. The overall prevalence
of CGD on Jeju Island is 23.1 in 1,000,000 individuals. Al-
though we tried to identify as many patients as possible, this
may be an underestimation of the actual prevalence of CGD
on Jeju Island.
We hypothesized that the high prevalence of CGD on Jeju
Island is associated with an identical mutation inherited from
a common ancestor or proband. According to the studies car-
ried out to date, the most common form of CGD is the X-
linked form. The approximately 30-40% of CGD are inher-
ited in an autosomal recessive traits. One of the rarest forms
of CGD is caused by mutations in CYBA gene, accounting
for only 5% of CGD patients (6). Up to the date, 27 muta-
tions in CYBA gene are listed in the Human Gene Mutation
Database (HGMD; http://www.hgmd.cf.ac.uk/ac/all.php) and
all 27 mutations reported for CYBA gene showed the allelic
heterogeneity with no preponderance of common affected
alleles or hot spots (16). However, all CGD patients on Jeju
Island had an identical, homozygous mutation in the CYBA
gene and six different SNPs within the CYBA gene in the
same manner. Moreover, one of the reported Japanese patients
with p22-phox-deficient CGD, sharing the same mutation
with CGD patients on Jeju Island, has consanguineous par-
ents (14). In regions with a higher incidence of consanguin-
ity in the population, there is an increase in the prevalence
of autosomal recessive genetic disorders, including CGD, as
a direct result of a higher rate of inbreeding (10, 11). Alto-
gether, these results strongly suggest that there might have
been unique marriage patterns similar to endogamy or con-
sanguineous marriage on Jeju Island.
In contrast to previous reports (13-16), a normal level of
gp91-phox protein expression was detected in all CGD pa-
tients on Jeju Island. By using transgenic expression of gp91-
phox and p22-phox in monkey kidney COS7 cells, which
lack endogenous p22-phox and gp91-phox expression, gp91-
phox was expressed on the cell surface in the absence of p22-
phox expression. However, co-expression of gp91-phox and
p22-phox were required to support the generation of oxygen
radicals in a cell-free NADPH oxidase assay (17). This im-
plies that the association of p22-phox with gp91-phox may
be essential for regulation of electron transfer in the redox
cycle, but p22-phox may not be necessary for the expression
of gp91-phox protein. Further studies are required to under-
stand the expression of gp91-phox in p22-phox-deficient
CGD.
Based on different clinical parameters, X-linked CGD has
a different, more severe, clinical phenotype than the autoso-
mal recessive CGD (6). The prognosis of X-linked CGD and
p22-phox-deficient CGD was not better than that of p47-
phox-deficient CGD (10), and p22-phox-deficient CGD with
the young age at diagnosis appears to be as severe as X-linked
CGD (16). Although genetic study has not been performed,
X-linked CGD had a significantly earlier age of symptom
onset and age at diagnosis than autosomal recessive CGD in
Korea (18). To our knowledge, there were only 2 reports about
the genetic analysis of X-linked CGD in Korea (19, 20). It
is hard to evaluate the clinical course of CGD patients on Jeju
Island in comparison with the different genotype. However,
the clinical course of CGD patients on Jeju Island seems to
be considered mild in that 30% of the living patients are 20
yr of age or older. 
There is an increase in the prevalence of autosomal reces-
sive genetic disorders in regions with a higher incidence of
consanguinity in the population, as a result of a higher rate
of inbreeding. All the CGD patients tested on Jeju Island
had an identical and homozygous mutation in the CYBA
gene. This result is specific to our cohort, as the most com-
mon form of CGD in other reports is the X-linked form of
CGD. Even though this study is not a nationwide survey of
CGD in Korea, the finding of an identical mutation in a sin-
gle region with a highly prevalent rate is quite unique. This
is not consistent with the generally accepted principle of reces-
sively inherited rare diseases. In Korea, there is a law prohibit-
ing marriage between people with the same surname and the
same family origin. However, since Jeju Island has been a
geologically isolated region for a long time, there might have
been unique marriage patterns similar to endogamy or con-
sanguineous marriage. This may explain the unusual identi-
cal mutation of the CYBA gene and the high prevalence of
autosomal recessive forms of CGD on Jeju Island. We are pre-
paring to investigate the genotyping further by using mic-
rosatellite markers. This approach may help to elucidate the
genetic characteristics of the population by revealing a par-
ticular familial structure on Jeju Island.
In this study, six SNPs within the CYBA gene were detected
in the course of genetic analysis. Although we did not check
for these SNP sites in a larger scale population, two SNPs in
the CYBA gene have not yet been registered as a polymor-
phism in the database of SNPs (http://www.ncbi.nih.gov/
SNP/): one located at nucleotide position G-36>A, which
changes 13 Q codon GGG into the alternative Q codon GGA;
and the other at nucleotide position 646 C>T in the 3′ un-
translated region of the CYBA gene. 1050 Y.M. Kim, J.E. Park, J.Y. Kim, et al.
In conclusion, we demonstrate all patients of CGD in Jeju
Island have an identical, homozygous mutation in the CYBA
gene. 
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